In a tMCAo rat model, CDK5miR intra-hippocampal injections attenuated neuronal shrinkage induced by ischemia and inhibited neuronal (NeuN) loss and Bax (bcl-2–associated X) immunoreactivity levels in CA1 one month after ischemia [64]. This evidence concerns the gene BAX and ischemia.